Edition:
United States

Becton Dickinson and Co (BDX)

BDX on New York Consolidated

205.63USD
24 Jul 2017
Change (% chg)

$0.33 (+0.16%)
Prev Close
$205.30
Open
$205.19
Day's High
$205.94
Day's Low
$204.40
Volume
1,627,597
Avg. Vol
1,661,044
52-wk High
$205.94
52-wk Low
$161.29

Latest Key Developments (Source: Significant Developments)

BD reports extension of exchange offers and consent solicitations for C. R. Bard notes
Monday, 3 Jul 2017 06:00am EDT 

July 3 (Reuters) - Becton Dickinson and Co ::BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes.Becton Dickinson And Co - amended exchange offers and consent solicitations to extend expiration date to 12:01 a.m., New York City time, on Aug 1​.  Full Article

FlowJo says established a strategic relationship with Becton Dickinson to catalyze coordination of resources for research market
Tuesday, 13 Jun 2017 06:59am EDT 

June 13 (Reuters) - Becton Dickinson And Co :Flowjo- Co, Becton Dickinson have established a strategic relationship to catalyze coordination of resources, people and data for research market.Flowjo says under agreement, companies are collaborating to offer cloud-based platform, flowjo envoy, with bd facsymphony.  Full Article

Becton Dickinson & Co and Bard get second requests from ftc under Hart-Scott-Rodino Act
Friday, 9 Jun 2017 05:15pm EDT 

June 9 (Reuters) - C R Bard Inc :Becton Dickinson and Co says co, Bard get second requests from ftc under Hart-Scott-Rodino act; cos continue to expect transaction to close in the fall of 2017‍​‍​.  Full Article

BD receives FDA 510(k) clearance for molecular test for harmful intestinal bacteria causing infectious diarrhea
Monday, 5 Jun 2017 06:59am EDT 

June 5 (Reuters) - Becton Dickinson And Co :BD receives FDA 510(K) clearance for molecular test for harmful intestinal bacteria causing infectious diarrhea.  Full Article

Becton Dickinson announces results of early tenders and amendments to exchange offers
Friday, 19 May 2017 06:00am EDT 

May 19 (Reuters) - Becton Dickinson And Co :BD announces results of early tenders and amendments to exchange offers.Becton Dickinson and Co - BD announced has amended exchange offer and consent solicitation in respect of Bard's 3.000% notes due 2026.Becton Dickinson -amendment to extend withdrawal rights for exchange offer, consent solicitation through to expiration date of exchange offer.  Full Article

Becton Dickinson and Co entered into a three-year term loan agreement
Tuesday, 16 May 2017 05:34pm EDT 

May 16 (Reuters) - Becton Dickinson And Co :On May 12, 2017, Becton Dickinson and Company entered into a three-year term loan agreement - SEC filing.Becton Dickinson and Co says three-year term loan agreement provides for a $2.25 billion term loan facility.Term loan facility will be unsecured.Covenants in term loan agreement are same as those in co's existing five year credit facility dated as of January 29, 2016.Proceeds may be used only to pay for portion of cash consideration due in connection with pending acquisition of C. R. Bard.Loans under term loan facility will have interest rate equal to either eurodollar rate, plus margin of 112.5-200 basis points.  Full Article

Retractable Technologies announces litigation update and results for the Q1 of 2017
Monday, 15 May 2017 05:55pm EDT 

May 15 (Reuters) - Retractable Technologies Inc :Announces litigation update and results for the first quarter of 2017.Bench trial in case of Retractable Technologies, Inc. v. Becton, Dickinson and Company was held on May 11 in court.Ultimate outcome of this suit could have a material effect on financial condition.Court announced that it will issue its decision within 3 months.  Full Article

BD announces exercise of option to purchase additional shares by underwriters of public equity offerings
Friday, 12 May 2017 06:00am EDT 

May 12 (Reuters) - Becton Dickinson and Co : :BD announces exercise of option to purchase additional shares by underwriters of public equity offerings increasing total gross proceeds to $4.95 billion.Says with exercise of options, total gross proceeds for offerings is approximately $4.95 billion.Becton Dickinson-to use proceeds from offerings to finance portion of cash consideration payable in connection with announced acquisition of C. R. Bard.  Full Article

BD prices offerings of common stock depositary shares
Thursday, 11 May 2017 04:49am EDT 

May 11 (Reuters) - Becton Dickinson And Co ::Prices offerings of $2.25 billion of common stock and $2.25 billion of depositary shares representing interests in mandatory convertible preferred stock.Priced its offerings of $2.25 billion of common stock par value $1.00 per share at a public offering price of $176.50 per share.Priced offerings of $2.25 billion of depositary shares par value $1.00 per share, at a public offering price of $50.00 /share.  Full Article

BD Q2 earnings per share $1.58
Tuesday, 2 May 2017 06:00am EDT 

May 2 (Reuters) - Becton Dickinson And Co :BD announces results for 2017 second fiscal quarter.Q2 earnings per share $1.58.Q2 revenue $2.969 billion versus I/B/E/S view $2.92 billion.Q2 earnings per share view $2.23 -- Thomson Reuters I/B/E/S.Reaffirms fy 2017 earnings per share view $7.73 to $7.83.Q2 adjusted earnings per share $2.30.Sees FY 2017 revenue down 3.5 to 4 percent.Reaffirms FY 2017 adjusted earnings per share view $9.35 to $9.45.Becton Dickinson- sees unfavorable impact to FY 2017 of approximately $50 to $60 million to revenues and approximately $0.20 to $0.25 to adjusted eps.Becton Dickinson And Co - on a currency-neutral basis, co continues to expect fy adjusted diluted earnings per share to be between $9.70 and $9.80.Becton Dickinson And Co- as reported, company now expects full fiscal year 2017 diluted earnings per share to be between $7.73 and $7.83.Becton Dickinson- on a currency-neutral basis, continues to expect full fiscal year adjusted diluted earnings per share to be between $9.70 and $9.80.Q2 earnings per share view $2.23, revenue view $2.92 billion -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $9.44, revenue view $12.04 billion -- Thomson Reuters I/B/E/S.Becton Dickinson- including estimated negative impact from foreign currency, co continues to expect adjusted earnings per share to be between $9.35 and $9.45 for fy.  Full Article

BRIEF-BD receives FDA clearance for new immunological diagnostic system

* BD receives FDA 510(k) clearance for new immunological diagnostic system Source text for Eikon: Further company coverage: